| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| BRM-421 | BRM-421 | Phase 3 Clinical | Brim Biotechnology Co Ltd | Dry Eye Syndromes; Keratoconjunctivitis Sicca; Xerophthalmia | Details |
| DVC1-0401 | DVC1-0401 | Phase 2 Clinical | Id Pharma, Kyushu University | Retinitis Pigmentosa | Details |